Apolipoprotein B and oxLDL levels in plasma of patients with diabetes, cardiovascular disease, and COVID-19

Authors

DOI:

https://doi.org/10.15407/dopovidi2021.06.126

Keywords:

COVID-19, type 2 diabetes, cardiovascular disease, apolipoprotein B, oxidized LDL

Abstract

Elevated levels of low-density lipoprotein (LDL-X) cholesterol, apolipoprotein B (ApoB), and especially oxidized LDL in plasma are associated with an increased risk of cardiovascular disease (CVD). The aim of the study was to determine the levels of ApoB and oxLDL in the blood of patients with diabetes mellitus (DM), CVD and COVID-19. ApoB and oxLDL were determined using enzyme-linked immunosorbent assay kits (Elabscience, USA). The measurements were performed at an optical wavelength of 450 nm. It was found that ApoB and oxLDL levels in the blood of patients with diabetes and, especially, with COVID-19 are substantially higher than in the blood of healthy people. Blood levels of ApoB and oxLDL are higher in patients with both COVID-19 and diabetes or CVD as com pared to patients with COVID-19 without comorbidities. Thus, the levels of ApoB and oxidized LDL may be the promising markers of severe COVID-19.

References

Khatana, C., Saini, N. K., Chakrabarti, S., Saini, V., Sharma, A., Saini, R. V. & Saini, A. K. (2020). Mechanistic Insights into the oxidized low-density lipoprotein-induced atherosclerosis. Oxid. Med. Cell. Longev., No. 2020, 5245308. https://doi.org/10.1155/2020/5245308

Devaraj, S., Semaan, J. R. & Jialal, I. (2021). Biochemistry, apolipoprotein B. In StatPearls. Treasure Island (FL): StatPearls Publishing.

Mao, Y., Xu, Y. & Lu, L. (2017). The nonlinear association between apolipoprotein B to apolipoprotein A1 ratio and type 2 diabetes. Medicine (Baltimore), 96, No. 1, e5834. https://doi.org/10.1097/MD.0000000000005834. Erratum: Medicine (Baltimore), 96, No. 12, e6541. Erratum: Medicine (Baltimore), 96, No. 17, e6821.

Dong, H., Chen, W., Wang, X., Pi, F., Wu, Y., Pang, S., Xie, Y., Xia, F. & Zhang, Q. (2015). Apolipoprotein A1, B levels, and their ratio and the risk of a first stroke: a meta-analysis and case-control study. Metab. Brain Dis,. 30, No. 6, pp. 1319-1330. https://doi.org/10.1007/s11011-015-9732-7

Sokolova, L. K., Pushkarev, V. M., Pushkarev, V. V., Kovzun, O. I. & Tronko, M. D. (2017). Diabetes mellitus and atherosclerosis. The role of inflammatory processes in pathogenesis (literature review). International journal of endocrinology (Ukraine), 13, No. 7, pp. 486-498 (in Russian). https://doi.org/10.22141/2224-0721.13.7.2017.115747

Sniderman, A. D., Thanassoulis, G., Glavinovic, T., Navar, A. M., Pencina, M., Catapano, A. & Ference, B. A. (2019). Apolipoprotein B particles and cardiovascular disease: a narrative review. JAMA Cardiol., 4, No. 12, pp. 1287-1295. https://doi.org/10.1001/jamacardio.2019.3780

Yan, Y., Song, D., Wu, J. & Wang, J. (2020). Long non-coding RNAs link oxidized low-density lipoprotein with the inflammatory response of macrophages in atherogenesis. Front. Immunol., No. 11, pp. 24. https://doi.org/10.3389/fimmu.2020.00024

Sokolova, L. K. (2014). Risk factors and clinical and diagnostic aspects of cardiovascular pathology in patients with types 1 and 2 diabetes mellitus. (Extended abstract of Doctor thesis). V.P. Komisarenko State Institute of Endocrinology and Metabolism of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine (in Ukrainian).

Kočar, E., Režen, T. & Rozman, D. (2021). Cholesterol, lipoproteins, and COVID-19: basic concepts and clinical applications. Biochim. Biophys. Acta. Mol. Cell Biol. Lipids, 1866, No. 2, 158849. https://doi.org/10.1016/j.bbalip.2020.158849

Wei, X., Zeng, W., Su, J., Wan, H., Yu, X., Cao, X., Tan, W. & Wang, H. (2020). Hypolipidemia is associated with the severity of COVID-19. J. Clin. Lipidol., 14, No. 3, pp. 297-304. https://doi.org/10.1016/j.jacl.2020.04.008

Fogacci, F., Borghi, C. & Cicero, A. F. G. (2020). Misinterpreting data in lipidology in the era of COVID-19. J. Clin. Lipidol., 14, No. 4, pp. 543-544. https://doi.org/10.1016/j.jacl.2020.07.004

Tronko, M. D., Cherviakova, S. A., Pushkarev, V. V., Belchina, Y. B., Kovzun, O. I., Pushkarev, V. M. & Sokolova, L. K. (2021). Apolipoprotein A1 level in plasma of patients with diabetes and diabetics patients with COVID-19 as a possible marker of disease. Dopov. Nac. akad. nauk Ukr., No. 4, pp. 110-113. https://doi.org/10.15407/dopovidi2021.04.110

Downloads

Published

23.12.2021

How to Cite

Tronko, M. ., Cherviakova, S. ., Pushkarev, V. ., Belchina, Y. ., Kovzun, O. ., Pushkarev, V. ., & Sokolova, L. . (2021). Apolipoprotein B and oxLDL levels in plasma of patients with diabetes, cardiovascular disease, and COVID-19. Reports of the National Academy of Sciences of Ukraine, (6), 126–130. https://doi.org/10.15407/dopovidi2021.06.126